IL6 and ovarian serous adenocarcinoma: No significant difference was found in concentrations of CRP, SAA, IL6 or IL8 between serous and non-serous ovarian cancer patients (Figure 2), suggesting that unlike CA125, these biomarkers could more effectively discriminate non-serous ovarian cancer cases from control and/or benign patients.